Study on the Causes and Clinical Treatment Methods of Irregular Vaginal Bleeding in Obstetrics and Gynecology
Lin-Jie Sui ( Sir Run Run Hospital of Nanjing Medical University, Nanjing, Jiangsu, 211100, China )
https://doi.org/10.37155/3060-8708-0102-3Abstract
Objective: To analyze the causes and clinical treatment methods for abnormal vaginal bleeding (AVB) in obstetrics and gynecology. Methods: A total of 74 patients with obstetrics and gynecology AVB admitted to our hospital from August 2023 to August 2024 were selected for this study. The causes of AVB were analyzed, and the patients were divided into a control group (37 cases) receiving conventional treatment and an observation group (37 cases) receiving combined treatment with oral anti-inflammation tablets by random number table method. The clinical effcacy of both groups was compared. Results: Among the 74 AVB patients, 24.32% had intrauterine devices (IUDs), 18.92% had ovarian tumors, 14.86% had endometrial cancer, 13.51% had endometriosis, 12.16% had reproductive tract infections, 9.46% had uterine fbroids, and 6.76% were classifed as other causes. The treatment effcacy in the observation group was signifcantly higher than that in the control group, while the incidence of adverse reactions, the amount of bleeding, and the duration of bleeding were signifcantly lower in the observatioAbstract:Objective: To analyze the causes and clinical treatment methods for abnormal vaginal bleeding (AVB) in obstetrics and gynecology. Methods: A total of 74 patients with obstetrics and gynecology AVB admitted to our hospital from August 2023 to August 2024 were selected for this study. The causes of AVB were analyzed, and the patients were divided into a control group (37 cases) receiving conventional treatment and an observation group (37 cases) receiving combined treatment with oral anti-inflammation tablets by random number table method. The clinical effcacy of both groups was compared. Results: Among the 74 AVB patients, 24.32% had intrauterine devices (IUDs), 18.92% had ovarian tumors, 14.86% had endometrial cancer, 13.51% had endometriosis, 12.16% had reproductive tract infections, 9.46% had uterine fbroids, and 6.76% were classifed as other causes. The treatment effcacy in the observation group was signifcantly higher than that in the control group, while the incidence of adverse reactions, the amount of bleeding, and the duration of bleeding were signifcantly lower in the observation group (P < 0.05). Conclusion: Analyzing the causes of obstetrics and gynecology AVB and incorporating Kang gong yan Pian into the treatment can enhance effcacy and expedite hemostasis, making it worthy of promotion. Keywords:Obstetrics and gynecology; abnormal vaginal bleeding; causes; Kang gong yan Pianbstetrics and gynecology AVB and incorporating Kang gong yan Pian into the treatment can enhance effcacy and expedite hemostasis, making it worthy of promotion.
Keywords
Obstetrics and gynecology; abnormal vaginal bleeding; causes; Kang gong yan PianFull Text
PDFReferences
[2] Wen Yuhua,Tan Zhiqin,Li Yafang,Zhou Xin. Study on the efficacy of mifepristone and estradiol valerate in the treatment of irregular vaginal bleeding after placement of Mannitol[J]. Joint Military Medicine,2023,37(10):861-865.
[3] Li Weimei. Clinical analysis of dienogest combined with laparoscopic surgery for the treatment of moderate to severe endometriosis combined with infertility[J]. Jiangxi Medicine,2021,56(7):1047-1048+1071.
[4] Xu Jiantao, Song Ting, Liu Guobiao. Characterizationof MRI diagnostic images of acquired uterine arteriovenous malformation[J]. Imaging Research and Medical Application,2023,7(13):27-30.
[5] He Yuanyuan. Diagnostic value of ultrasonography in irregular vaginal bleeding[J]. Journal of Women's and Children's Health,2023,2(3):28-30.
[6] Li Yan,Ji Guoqiang. Observation of endometrial pathologic types and clinicopathologic features in patients with uterine fibroids[J]. Journal of Henan Medical College,2023,35(1):41-43.
[7] Zhang Jianping,Yang Jiangyan. Clinical effects of different doses of mifepristone in the treatment of perimenopausal irregular vaginal bleeding[J]. Journal of Clinical Rational Drug Use,2022,15(32):110-112.
Copyright © 2024 Lin-Jie Sui

This work is licensed under a Creative Commons Attribution 4.0 International License